Stock Research for AXIM

AXIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AXIM Stock Chart & Research Data

The AXIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AXIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AXIM Due diligence Resources & Stock Charts

The AXIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AXIM Detailed Price Forecast - CNN Money CNN View AXIM Detailed Summary - Google Finance
Yahoo View AXIM Detailed Summary - Yahoo! Finance Zacks View AXIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AXIM Trends & Analysis - Trade-Ideas Barrons View AXIM Major Holders - Barrons
NASDAQ View AXIM Call Transcripts - NASDAQ Seeking View AXIM Breaking News & Analysis - Seeking Alpha
Spotlight View AXIM Annual Report - CompanySpotlight.com OTC Report View AXIM OTC Short Report - OTCShortReport.com
TradeKing View AXIM Fundamentals - TradeKing Charts View AXIM SEC Filings - Bar Chart
WSJ View Historical Prices for AXIM - The WSJ Morningstar View Performance/Total Return for AXIM - Morningstar
MarketWatch View the Analyst Estimates for AXIM - MarketWatch CNBC View the Earnings History for AXIM - CNBC
StockMarketWatch View the AXIM Earnings - StockMarketWatch MacroAxis View AXIM Buy or Sell Recommendations - MacroAxis
Bullish View the AXIM Bullish Patterns - American Bulls Short Pains View AXIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AXIM Stock Mentions - StockTwits PennyStocks View AXIM Stock Mentions - PennyStockTweets
Twitter View AXIM Stock Mentions - Twitter Invest Hub View AXIM Investment Forum News - Investor Hub
Yahoo View AXIM Stock Mentions - Yahoo! Message Board Seeking Alpha View AXIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AXIM - SECform4.com Insider Cow View Insider Transactions for AXIM - Insider Cow
CNBC View AXIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AXIM - OTC Markets
Yahoo View Insider Transactions for AXIM - Yahoo! Finance NASDAQ View Institutional Holdings for AXIM - NASDAQ


Stock Charts

FinViz View AXIM Stock Insight & Charts - FinViz.com StockCharts View AXIM Investment Charts - StockCharts.com
BarChart View AXIM Stock Overview & Charts - BarChart Trading View View AXIM User Generated Charts - Trading View




Latest Financial News for AXIM


New U.S. Patent Allowance Granted To Axim® Biotechnologies For Anti-Microbial Compositions Comprising Cannabinoids
Posted on Thursday August 08, 2019

NEW YORK, Aug. 08, 2019 -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech,” “AXIM” or “the Company”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today.


Cannabinoid R&D Updates: Medical Marijuana Inc And Axim Biotech
Posted on Friday August 02, 2019

Medical Marijuana, Inc. (OTC: MJNA) subsidiary Kannaway has entered a strategic partnership with Endocanna Health, a research and development biotechnology company specializing in endocannabinoid DNA testing and personalization. Under the terms of the agreement, Endocanna will manufacture its patent-pending Endocannabinoid DNA Test Kits and license its proprietary DNA technology to Kannaway.


AXIM® Biotechnologies Launches AXIM® Wellness Division Focused on Cannabinoid-Based Nutraceutical Products and Announces New Product Pipeline
Posted on Tuesday July 30, 2019

AXIM® Biotechnologies, Inc. (AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has launched its AXIM® Wellness division that will be focused on bringing consumers premium cannabinoid-based nutraceutical products. AXIM® Wellness division will address the high demand for cannabinoid-based solutions worldwide through a series of patented nutraceutical products.


AXIM® Biotechnologies Receives Seventh Private Label Gum Purchase Order Pushing Orders to Nearly $900,000 for Last Five Months
Posted on Thursday July 11, 2019

NEW YORK, July 11, 2019 -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development,.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.